Comparative performance of composite measures from two phase III clinical trials of ixekizumab in psoriatic arthritis.

Laura C CoatesJosef S SmolenPhillip J MeaseM Elaine HusniJoseph F MerolaEric LespessaillesKishimoto MitsumasaLisa MacphersonAndrew J BradleyRebecca BolcePhilip S Helliwell

Published in: RMD open (2022)

NCT01695239.

Keyphrases